Pharmaceutical Technology-03-01-2012

Issue PDF
Pharmaceutical Technology

March 01, 2012

Solid Dosage and Excipients

Pharmaceutical Technology

The author reviews significant changes to GMP for excipients in the forthcoming American National Standard, including a risk-based approach to excipient manufacture, why new requirements were proposed, and their potential impact to excipient manufacturers.

The article examines some recent developments for this process step and for continuous manufacturing overall.

Pharmaceutical Technology
Articles

March 01, 2012

This article provides guidance for industry on how to comply with the pending American National Standard on excipient GMP, with a focus on risk assessment.

Pharmaceutical Technology

This article considers the different conditions to which the powder is subjected in the tableting process, and discusses which powder properties should be measured to accurately reflect likely powder behavior in the process.

Pharmaceutical Technology
Articles

March 01, 2012

Pharmaceutical companies, equipment providers, contract-service providers, and excipient manufacturers apply various approaches for improving solubility. The article examines some recent developments.

Pharmaceutical Technology
Articles

March 01, 2012

Taste-masking is an important consideration to ensure patient compliance.

Pharmaceutical Technology

Experts in solid dosage discuss the formulation and manufacture of multilayer tablets.

Articles
Pharmaceutical Technology

March 01, 2012

FDA answers key questions about the October 2011 guidance on using physical–chemical identifiers in solid oral dosage products to help prevent and avoid counterfeiting.